• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素受体对脂肪来源干细胞活性在活力和成骨分化方面的调控

Regulation of Adipose-Derived Stem Cell Activity by Melatonin Receptors in Terms of Viability and Osteogenic Differentiation.

作者信息

Skubis-Sikora Aleksandra, Sikora Bartosz, Małysiak Weronika, Wieczorek Patrycja, Czekaj Piotr

机构信息

Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland.

出版信息

Pharmaceuticals (Basel). 2023 Sep 1;16(9):1236. doi: 10.3390/ph16091236.

DOI:10.3390/ph16091236
PMID:37765045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10535461/
Abstract

Melatonin is a hormone secreted mainly by the pineal gland and acts through the Mel1A and Mel1B receptors. Among other actions, melatonin significantly increases osteogenesis during bone regeneration. Human adipose-derived mesenchymal stem cells (ADSCs) are also known to have the potential to differentiate into osteoblast-like cells; however, inefficient culturing due to the loss of properties over time or low cell survival rates on scaffolds is a limitation. Improving the process of ADSC expansion in vitro is crucial for its further successful use in bone regeneration. This study aimed to assess the effect of melatonin on ADSC characteristics, including osteogenicity. We assessed ADSC viability at different melatonin concentrations as well as the effect on its receptor inhibitors (luzindole or 4-P-PDOT). Moreover, we analyzed the ADSC phenotype, apoptosis, cell cycle, and expression of and receptors, and its potential for osteogenic differentiation. We found that ADSCs treated with melatonin at a concentration of 100 µM had a higher viability compared to those treated at higher melatonin concentrations. Melatonin did not change the phenotype of ADSCs or induce apoptosis and it promoted the activity of some osteogenesis-related genes. We concluded that melatonin is safe, non-toxic to normal ADSCs in vitro, and can be used in regenerative medicine at low doses (100 μM) to improve cell viability without negatively affecting the osteogenic potential of these cells.

摘要

褪黑素是一种主要由松果体分泌的激素,通过Mel1A和Mel1B受体发挥作用。在其他作用中,褪黑素在骨再生过程中能显著促进成骨作用。人脂肪来源的间充质干细胞(ADSCs)也已知具有分化为成骨样细胞的潜力;然而,由于随着时间推移特性丧失导致的低效培养或在支架上的低细胞存活率是一个限制因素。改善ADSCs体外扩增过程对于其在骨再生中的进一步成功应用至关重要。本研究旨在评估褪黑素对ADSCs特性(包括成骨能力)的影响。我们评估了不同褪黑素浓度下ADSCs的活力以及其受体抑制剂(鲁辛朵或4-P-PDOT)的作用。此外,我们分析了ADSCs的表型、凋亡、细胞周期以及 和 受体的表达,及其成骨分化潜力。我们发现,与用较高浓度褪黑素处理的ADSCs相比,用100 μM浓度褪黑素处理的ADSCs具有更高的活力。褪黑素没有改变ADSCs的表型或诱导凋亡,并且它促进了一些与成骨相关基因的活性。我们得出结论,褪黑素在体外对正常ADSCs是安全、无毒的,并且可以以低剂量(100 μM)用于再生医学,以提高细胞活力而不会对这些细胞的成骨潜力产生负面影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/e66f140e8faa/pharmaceuticals-16-01236-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/aa5f4a0265c9/pharmaceuticals-16-01236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/35bc34d1a89b/pharmaceuticals-16-01236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/2cb9b100e158/pharmaceuticals-16-01236-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/96a692b5da80/pharmaceuticals-16-01236-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/58fce8f0a4c0/pharmaceuticals-16-01236-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/e36a4008b506/pharmaceuticals-16-01236-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/8d96afbeae32/pharmaceuticals-16-01236-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/e66f140e8faa/pharmaceuticals-16-01236-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/aa5f4a0265c9/pharmaceuticals-16-01236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/35bc34d1a89b/pharmaceuticals-16-01236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/2cb9b100e158/pharmaceuticals-16-01236-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/96a692b5da80/pharmaceuticals-16-01236-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/58fce8f0a4c0/pharmaceuticals-16-01236-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/e36a4008b506/pharmaceuticals-16-01236-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/8d96afbeae32/pharmaceuticals-16-01236-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b9/10535461/e66f140e8faa/pharmaceuticals-16-01236-g008.jpg

相似文献

1
Regulation of Adipose-Derived Stem Cell Activity by Melatonin Receptors in Terms of Viability and Osteogenic Differentiation.褪黑素受体对脂肪来源干细胞活性在活力和成骨分化方面的调控
Pharmaceuticals (Basel). 2023 Sep 1;16(9):1236. doi: 10.3390/ph16091236.
2
Osteogenic differentiation of rat mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells: melatonin as a differentiation factor.大鼠脂肪组织间充质干细胞与骨髓间充质干细胞成骨分化的比较:褪黑素作为一种分化因子
Iran Biomed J. 2008 Jul;12(3):133-41.
3
Comparison of The Melatonin Preconditioning Efficacy between Bone Marrow and Adipose-Derived Mesenchymal Stem Cells.骨髓间充质干细胞与脂肪来源间充质干细胞褪黑素预处理效果的比较
Cell J. 2019 Jan;20(4):450-458. doi: 10.22074/cellj.2019.5507. Epub 2018 Aug 1.
4
Effects of melatonin on the proliferation and differentiation of rat adipose-derived stem cells.褪黑素对大鼠脂肪来源干细胞增殖和分化的影响。
Indian J Plast Surg. 2008 Jan;41(1):8-14. doi: 10.1055/s-0039-1699220.
5
Pharmacological activation of TAZ enhances osteogenic differentiation and bone formation of adipose-derived stem cells.TAZ 的药理学激活增强脂肪来源干细胞的成骨分化和骨形成。
Stem Cell Res Ther. 2018 Mar 7;9(1):53. doi: 10.1186/s13287-018-0799-z.
6
Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicine.与性别和年龄匹配的正常对照相比,硬皮病中人类脂肪来源干细胞的特征:对再生医学的启示。
Stem Cell Res Ther. 2017 Feb 7;8(1):23. doi: 10.1186/s13287-016-0444-7.
7
Chemical group-dependent plasma polymerisation preferentially directs adipose stem cell differentiation towards osteogenic or chondrogenic lineages.化学基团依赖性等离子体聚合优先引导脂肪干细胞向成骨或软骨生成谱系分化。
Acta Biomater. 2017 Mar 1;50:450-461. doi: 10.1016/j.actbio.2016.12.016. Epub 2016 Dec 9.
8
Melatonin enhances osteogenic differentiation of dental pulp mesenchymal stem cells by regulating MAPK pathways and promotes the efficiency of bone regeneration in calvarial bone defects.褪黑素通过调节 MAPK 通路增强牙髓间充质干细胞的成骨分化,提高颅骨骨缺损中骨再生的效率。
Stem Cell Res Ther. 2022 Feb 19;13(1):73. doi: 10.1186/s13287-022-02744-z.
9
Three-dimensional printed polycaprolactone-based scaffolds provide an advantageous environment for osteogenic differentiation of human adipose-derived stem cells.三维打印的聚己内酯基支架为人类脂肪来源干细胞的成骨分化提供了有利的环境。
J Tissue Eng Regen Med. 2018 Jan;12(1):e473-e485. doi: 10.1002/term.2310. Epub 2017 Apr 11.
10
Three-Dimensional Printed Titanium Scaffolds Enhance Osteogenic Differentiation and New Bone Formation by Cultured Adipose Tissue-Derived Stem Cells Through the IGF-1R/AKT/Mammalian Target of Rapamycin Complex 1 (mTORC1) Pathway.三维打印钛支架通过 IGF-1R/AKT/雷帕霉素靶蛋白复合物 1(mTORC1)通路增强脂肪组织来源干细胞的成骨分化和新骨形成。
Med Sci Monit. 2019 Oct 27;25:8043-8054. doi: 10.12659/MSM.918517.

引用本文的文献

1
Challenges and future perspectives in using mesenchymal stem cells for efficient bone fracture healing.使用间充质干细胞促进高效骨折愈合的挑战与未来展望。
Front Bioeng Biotechnol. 2025 May 30;13:1568914. doi: 10.3389/fbioe.2025.1568914. eCollection 2025.
2
Designing an effective dissolution test for bilayer tablets tailored for optimal melatonin release in sleep disorder management.设计一种针对双层片的有效溶出度测试,该双层片专为睡眠障碍管理中褪黑素的最佳释放而定制。
Front Nutr. 2024 May 6;11:1394330. doi: 10.3389/fnut.2024.1394330. eCollection 2024.

本文引用的文献

1
Mesenchymal stem cells in the treatment of osteogenesis imperfecta.间充质干细胞在成骨不全治疗中的应用
Cell Regen. 2023 Feb 2;12(1):7. doi: 10.1186/s13619-022-00146-3.
2
Melatonin Inhibits the Ferroptosis Pathway in Rat Bone Marrow Mesenchymal Stem Cells by Activating the PI3K/AKT/mTOR Signaling Axis to Attenuate Steroid-Induced Osteoporosis.褪黑素通过激活 PI3K/AKT/mTOR 信号通路抑制大鼠骨髓间充质干细胞铁死亡通路,减轻激素诱导的骨质疏松症。
Oxid Med Cell Longev. 2022 Aug 18;2022:8223737. doi: 10.1155/2022/8223737. eCollection 2022.
3
Efficacy of Neoadjuvant Chemotherapy plus Limb-Sparing Surgery for Osteosarcoma and Its Impact on Long-Term Quality of Life.
新辅助化疗联合保肢手术治疗骨肉瘤的疗效及其对长期生活质量的影响
Evid Based Complement Alternat Med. 2022 Aug 8;2022:1693824. doi: 10.1155/2022/1693824. eCollection 2022.
4
Melatonin protects gingival mesenchymal stem cells and promotes differentiation into osteoblasts.褪黑素保护牙龈间充质干细胞并促进其向成骨细胞分化。
Cell Biochem Funct. 2022 Aug;40(6):636-646. doi: 10.1002/cbf.3733. Epub 2022 Jul 18.
5
Melatonin Accelerates Osteoporotic Bone Defect Repair by Promoting Osteogenesis-Angiogenesis Coupling.褪黑素通过促进成骨-血管生成偶联加速骨质疏松性骨缺损修复。
Front Endocrinol (Lausanne). 2022 Feb 22;13:826660. doi: 10.3389/fendo.2022.826660. eCollection 2022.
6
Melatonin enhances osteogenic differentiation of dental pulp mesenchymal stem cells by regulating MAPK pathways and promotes the efficiency of bone regeneration in calvarial bone defects.褪黑素通过调节 MAPK 通路增强牙髓间充质干细胞的成骨分化,提高颅骨骨缺损中骨再生的效率。
Stem Cell Res Ther. 2022 Feb 19;13(1):73. doi: 10.1186/s13287-022-02744-z.
7
Structural basis of the ligand binding and signaling mechanism of melatonin receptors.褪黑素受体配体结合和信号转导机制的结构基础。
Nat Commun. 2022 Jan 24;13(1):454. doi: 10.1038/s41467-022-28111-3.
8
Osteogenesis Imperfecta: Current and Prospective Therapies.成骨不全症:现有疗法与未来疗法。
Biomolecules. 2021 Oct 10;11(10):1493. doi: 10.3390/biom11101493.
9
Effect of Melatonin for Regulating Mesenchymal Stromal Cells and Derived Extracellular Vesicles.褪黑素对间充质基质细胞及衍生细胞外囊泡的调节作用。
Front Cell Dev Biol. 2021 Sep 1;9:717913. doi: 10.3389/fcell.2021.717913. eCollection 2021.
10
Melatonin as a Potential Multitherapeutic Agent.褪黑素作为一种潜在的多效治疗剂。
J Pers Med. 2021 Apr 6;11(4):274. doi: 10.3390/jpm11040274.